Get access to our best features
Get access to our best features
Published 1 year ago

Indian Immunologicals gets DCGI nod for Measles-Rubella vaccine

Summary by Ground News
Vaccine maker Indian Immunologicals (IIL) has received approval from the Drugs Controller General of India (DGCI) and Telangana State Drug Control Administration (DCA) for manufacturing Measles-Rubella (MR) vaccine. IIL is collaborating with Vietnam's Center for Research and Production of Vaccines and Biologicals, also known as Polyvac.

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources lean Left
100% Left

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)